Ascletis Pharma Inc
HKEX:1672

Watchlist Manager
Ascletis Pharma Inc Logo
Ascletis Pharma Inc
HKEX:1672
Watchlist
Price: 1.58 HKD -2.47%
Market Cap: 1.6B HKD
Have any thoughts about
Ascletis Pharma Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Ascletis Pharma Inc

Wall Street analysts forecast Ascletis Pharma Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascletis Pharma Inc is 2.03 HKD with a low forecast of 2.01 HKD and a high forecast of 2.09 HKD.

Lowest
Price Target
2.01 HKD
27% Upside
Average
Price Target
2.03 HKD
28% Upside
Highest
Price Target
2.09 HKD
32% Upside
Ascletis Pharma Inc Competitors:
Price Targets
CANTA
Cantargia AB
416% Upside
145020
Hugel Inc
20% Upside
ADAG
Adagene Inc
353% Upside
CRVO
Diffusion Pharmaceuticals Inc
424% Upside
ASND
Ascendis Pharma A/S
61% Upside
LGND
Ligand Pharmaceuticals Inc
7% Upside
ALLK
Allakos Inc
117% Upside
006280
Green Cross Corp
19% Upside

Revenue
Forecast

Revenue Estimate
Ascletis Pharma Inc

For the last 6 years the compound annual growth rate for Ascletis Pharma Inc's revenue is 1%. The projected CAGR for the next 3 years is 12%.

1%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ascletis Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Ascletis Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ascletis Pharma Inc's stock price target?
Price Target
2.03 HKD

According to Wall Street analysts, the average 1-year price target for Ascletis Pharma Inc is 2.03 HKD with a low forecast of 2.01 HKD and a high forecast of 2.09 HKD.

What is Ascletis Pharma Inc's Revenue forecast?
Projected CAGR
12%

For the last 6 years the compound annual growth rate for Ascletis Pharma Inc's revenue is 1%. The projected CAGR for the next 3 years is 12%.

Back to Top